ArticleApplied and environmental microbiology2026
Characterization of acetovanillone degradation in wild-type and engineered
Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reimagining Lignin Valorization: Synthetic Biology-Enabled Sustainable Aromatic Carbon Biomanufacturing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
There is considerable interest in harnessing bacterial catabolic activities to valorize lignin-derived compounds. One such class of compounds, hydroxyphenylethanones (HPEs), includes acetovanillone (AV), 4-hydroxyacetophenone (HAP), and acetosyringone (AS). Despite occurring in various industrial streams of lignin, there are few reports on their microbiological degradation. Here, we report that IMPORTANCE: As an abundant polymer in plants, lignin represents a renewable alternative to petroleum as a feedstock in the manufacture of chemicals. Strategies to convert lignin into higher-value compounds couple chemical and biological catalysis, where engineered microorganisms transform chemocatalytically generated mixtures of lignin-derived aromatic compounds, or LDACs. The development of microbial biocatalysts depends on the characterization and engineering of pathways that degrade LDACs. In this study, we identified a pathway that partially degrades an important class of LDACs in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.